We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.91B
AUM Growth
+$396M
Cap. Flow
+$287M
Cap. Flow %
15.09%
Top 10 Hldgs %
22.25%
Holding
1,595
New
496
Increased
417
Reduced
319
Closed
313

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$12.1M
2
BMBL icon
Bumble
BMBL
+$11.4M
3
NVDA icon
NVIDIA
NVDA
+$10M
4
MRCY icon
Mercury Systems
MRCY
+$6.22M
5
HUM icon
Humana
HUM
+$6.18M

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$14M
2
BEKE icon
KE Holdings
BEKE
+$12.7M
3
BABA icon
Alibaba
BABA
+$11.4M
4
SPLK
Splunk Inc
SPLK
+$11.1M
5
LI icon
Li Auto
LI
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 14.19%
2 Consumer Discretionary 10.36%
3 Healthcare 9.86%
4 Industrials 9.74%
5 Energy 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
1276
PUT
Akebia Therapeutics
AKBA
$234M
$23.8K ﹤0.01%
+13,000
New +$20.8K
TUYA
1277
Tuya Inc
TUYA
$1.12B
$19.1K ﹤0.01%
+10,919
New +$20.7K
LLAP
1278
DELISTED
Terran Orbital Corporation
LLAP
$14.2K ﹤0.01%
10,851
-51,689
-83% -$52.2K
NBSE
1279
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$7K ﹤0.01%
15,550
PSNYW icon
1280
Polestar Automotive Holding ADS Class C-1
PSNYW
$388M
$2.9K ﹤0.01%
551
SRZNW icon
1281
Surrozen Inc Warrant
SRZNW
$8.86K
$743 ﹤0.01%
24,614
KPLTW
1282
DELISTED
Katapult Holdings Warrant
KPLTW
$568 ﹤0.01%
28,680
ACAD icon
1283
Acadia Pharmaceuticals
ACAD
$5.07B
-16,595
Closed -$520K
ACHC icon
1284
Acadia Healthcare
ACHC
$2.96B
-5,289
Closed -$411K
ACHR icon
1285
Archer Aviation
ACHR
$4.71B
-129,345
Closed -$794K
ACLS icon
1286
Axcelis
ACLS
$4.09B
-1,788
Closed -$232K
ACMR icon
1287
ACM Research
ACMR
$5.69B
-442,190
Closed -$8.64M
ADNT icon
1288
Adient
ADNT
$1.46B
-13,684
Closed -$498K
ADT icon
1289
CALL
ADT
ADT
$5.51B
-192,500
Closed -$1.31M
AEYE icon
1290
AudioEye
AEYE
$71.3M
-29,400
Closed -$159K
AGEN
1291
Agenus
AGEN
$286M
-1,344
Closed -$22.3K
AGO icon
1292
Assured Guaranty
AGO
$3.38B
-10,483
Closed -$784K
AKAM icon
1293
Akamai
AKAM
$16.9B
-5,600
Closed -$663K
AL
1294
DELISTED
Air Lease Corp
AL
-6,463
Closed -$271K
ALGN icon
1295
Align Technology
ALGN
$12.5B
-1,340
Closed -$367K
AMBA icon
1296
Ambarella
AMBA
$3.69B
-5,272
Closed -$323K
AME icon
1297
Ametek
AME
$58.1B
-1,975
Closed -$326K
ANSS
1298
CALL
DELISTED
Ansys
ANSS
-2,200
Closed -$798K
AOUT icon
1299
American Outdoor Brands
AOUT
$161M
-11,135
Closed -$93.5K
APLS
1300
DELISTED
Apellis Pharmaceuticals
APLS
-8,240
Closed -$493K

Similar funds

Prelude Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Prelude Capital Management held 1,595 positions worth $1.91B, up 26% from $1.51B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management deployed $287M of net new capital in Q1 2024, opening 496 new positions and adding to 417 existing holdings. Its largest new stake was Mercury Systems: 206,337 shares worth $6.09M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was New Oriental, an estimated $14M trimmed.

  • Prelude Capital Management's largest Q1 2024 buy was Mercury Systems: 206,337 shares worth $6.09M.
  • Prelude Capital Management added most to Baidu in Q1 2024, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q1 2024 reduction was New Oriental, cutting an estimated $14M.
  • Prelude Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $11.1M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.91B portfolio in Q1 2024.
  • Prelude Capital Management opened 496 new positions and closed 313 in Q1 2024.
  • Prelude Capital Management's portfolio value rose 26% quarter-over-quarter to $1.91B.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.